Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Reactogenicity”

598 trials

Showing 20 of 598 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT07128121
What this trial is testing

Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus (RSV) Infection
Shenzhen Shenxin Biotechnology Co., Ltd 500
Testing effectiveness (Phase 2)Looking for participantsNCT06213506
What this trial is testing

A Study on the Safety, Reactogenicity, and Immune Response to the GVGH iNTS-GMMA Vaccine Against Invasive Nontyphoidal Salmonella in Adults, Children, and Infants

Who this might be right for
Salmonella Infections
GlaxoSmithKline 516
Testing effectiveness (Phase 2)Study completedNCT00129116
What this trial is testing

3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age

Who this might be right for
Haemophilus Influenzae Type bNeisseria Meningitidis
GlaxoSmithKline 388
Early research (Phase 1)Study completedNCT00153543
What this trial is testing

Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders

Who this might be right for
Pneumococcal Infections
Centers for Disease Control and Prevention 86
Testing effectiveness (Phase 2)Study completedNCT00230750
What this trial is testing

Inactivated Influenza A/H5N1 Vaccine in the Elderly

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 261
Large-scale testing (Phase 3)Study completedNCT00696891
What this trial is testing

Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in Adults

Who this might be right for
Hepatitis B
GlaxoSmithKline 380
Early research (Phase 1)Study completedNCT05292391
What this trial is testing

Safety, Tolerability, and Immunogenicity Study of Sm-p80 + GLA-SE (SchistoShield(R)) Vaccine in Healthy Adults

Who this might be right for
Schistosomiasis
National Institute of Allergy and Infectious Diseases (NIAID) 45
Testing effectiveness (Phase 2)Ended earlyNCT03610581
What this trial is testing

Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix

Who this might be right for
Human Papillomavirus Infections
Janssen Vaccines & Prevention B.V. 9
Large-scale testing (Phase 3)Study completedNCT00370396
What this trial is testing

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 1,200
Testing effectiveness (Phase 2)Active Not RecruitingNCT06143046
What this trial is testing

MRNA-1345 Vaccine Targeting Respiratory Syncytial Virus in Pregnant Women and in Infants Born to Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus
ModernaTX, Inc. 360
Early research (Phase 1)UnknownNCT04885361
What this trial is testing

To Evaluate the Safety, and Immunogenicity of Vaccine Candidate Against COVID-19, in Healthy Adults

Who this might be right for
Coronavirus Disease (COVID-19)
OSE Immunotherapeutics 48
Post-approval studies (Phase 4)Study completedNCT01198769
What this trial is testing

Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 15
Early research (Phase 1)Study completedNCT05135273
What this trial is testing

Study of the Transmission-Blocking Vaccine Pfs230D1-EPA/Matrix-M Against Malaria in Adults in Mali

Who this might be right for
Malaria,Falciparum
National Institute of Allergy and Infectious Diseases (NIAID) 80
Early research (Phase 1)Study completedNCT05148962
What this trial is testing

Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers

Who this might be right for
COVID-19
Gritstone bio, Inc. 45
Testing effectiveness (Phase 2)Study completedNCT04930003
What this trial is testing

Reactogenicity, Safety and Immunogenicity of QazCoVac-P COVID-19 Vaccine

Who this might be right for
Covid19SARS-CoV InfectionVaccine Adverse Reaction
Research Institute for Biological Safety Problems 244
Early research (Phase 1)Not Yet RecruitingNCT07406347
What this trial is testing

A Trial to Evaluate the Safety and Reactogenicity of an Investigational Pneumococcal Vaccine in Infants Receiving 3-dose Primary Dosing Series Followed by a Booster Dose at 12 to 15 Months of Age

Who this might be right for
Pneumonia, Bacterial
GlaxoSmithKline 60
Early research (Phase 1)Study completedNCT02458092
What this trial is testing

Evaluate the Safety and Efficacy of Plasmodium Falciparum Malaria Protein 010 (FMP010) Administered With Adjuvant AS01B

Who this might be right for
Malaria
U.S. Army Medical Research and Development Command 30
Testing effectiveness (Phase 2)Study completedNCT03589807
What this trial is testing

2013/2017 H7N9 Prime-Boost Interval

Who this might be right for
Avian InfluenzaInfluenza Immunisation
National Institute of Allergy and Infectious Diseases (NIAID) 180
Testing effectiveness (Phase 2)Study completedNCT05901636
What this trial is testing

A Clinical Study to Evaluate an Experimental Universal Influenza Vaccine, INFLUENZA G1 mHA, in Healthy Adults

Who this might be right for
Influenza Prevention
Janssen Vaccines & Prevention B.V. 170
Testing effectiveness (Phase 2)Study completedNCT03636906
What this trial is testing

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 201
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation